SCHEMBL1186255

SCHEMBL1186255

Cc1cccc2c(Br)c3ccccc3nc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
HCRTR1 O43613 1/20 0.46
RAB9A P51151 1/20 0.46
CYP1A2 P05177 2/20 0.44
PARP1 P09874 2/20 0.44
TNKS O95271 2/20 0.44
TNKS2 Q9H2K2 2/20 0.44
NQO2 P16083 2/20 0.43
GPR3 P46089 1/20 0.42
ELANE P08246 1/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP2A6 P11509 1/20 0.42
BACE1 P56817 1/20 0.42
TP53 P04637 1/20 0.41
KDM4E B2RXH2 4/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27977387 0.81 KDM1A (0.50) KDM1AMEN1KMT2ANPC1HCRTR1
SCHEMBL30182735 0.79 CYP1A2 (0.66) KDM1AMEN1KMT2ANPC1HCRTR1
SCHEMBL11060901 0.79 CYP1A2 (0.66) KDM1AMEN1KMT2ANPC1HCRTR1
SCHEMBL6791707 0.78 MAOA (0.61) KDM1AMEN1KMT2ANPC1HCRTR1
SCHEMBL12886828 0.78 KDM1A (0.48) KDM1AMEN1KMT2ANPC1HCRTR1
SCHEMBL17060429 0.78 CYP1A2 (0.50) KDM1AMEN1KMT2ANPC1HCRTR1
SCHEMBL1187000 0.77 KDM1A (0.51) KDM1AMEN1KMT2ANPC1RAB9A
SCHEMBL2512737 0.77 KDM4E (0.56) KDM1AKMT2ARAB9ACYP1A2NQO2
SCHEMBL1186246 0.75 KDM1A (0.46) KDM1AMEN1KMT2ANPC1HCRTR1
SCHEMBL13271201 0.74 ERN1 (0.55) KDM1AMEN1KMT2ANPC1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888509-B2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors GEORGETOWN UNIVERSITY (US) 2011-02-15 US disclosed
US-7888509-B2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors GEORGETOWN UNIVERSITY (US) 2011-02-15 US disclosed
US-20070276140-A1 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors GEORGETOWN UNIVERSITY (US) 2007-11-29 US disclosed
WO-2005043124-A2 CHIRAL 1,8-DIARYLNAPHTHALENES, METHODS OF MAKING THEM, AND THEIR USE AS SENSORS GEORGETOWN UNIVERSITY (US) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276140-A1 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors ALKBH2, ALKBH1, ALG3 KDM1A 620/4885MEN1 916/4885KMT2A 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.